What Every Cattle Producer Should Know About BLV
Bovine Leukemia Virus (BLV) holds the distinction of being the most common infectious disease of cattle in the United States. Estimates put 40-50% of dairy cattle and a lower but still significant percentage of beef cattle as infected. Despite those numbers, BLV flies under the radar because most infected cattle never develop clinical signs. But BLV does cause real economic losses through reduced milk production, shorter lifespans, and weakened immune function, which makes it worth knowing about and worth controlling.
The Virus
What Is BLV?
BLV is a retrovirus (family Retroviridae) that integrates into host cell DNA and infects white blood cells (lymphocytes). Once it takes hold, the infection lasts a lifetime. The virus is related to human T-cell leukemia virus (HTLV), though the two behave very differently.
Infection Outcomes
``` BLV INFECTION ↓ ┌────┴────┐ ↓ ↓ MOST (~70%) SOME (~30%) No visible Persistent disease lymphocytosis (carriers) (elevated WBC) │ │ │ ↓ │ ~5% develop │ LYMPHOSARCOMA │ (cancer) ↓ Lifelong carriers (can transmit) ```
| Outcome | Percentage | What It Looks Like |
|---|---|---|
| Asymptomatic infection | ~70% | None; positive on blood test |
| Persistent lymphocytosis (PL) | ~30% | Elevated lymphocyte counts; usually healthy |
| Lymphosarcoma (LS) | ~5% of infected | Tumors; eventually fatal |
How BLV Spreads
Transmission Routes
| Route | Mechanism | Risk Level |
|---|---|---|
| Blood contamination | Needles, equipment, surgical tools | HIGH |
| Biting insects | Horseflies, stable flies | MODERATE |
| Natural transmission | Dam to calf (blood exposure at birth) | LOW-MODERATE |
| Colostrum/milk | Virus present in milk | LOW (most calves protected by maternal antibodies) |
Herd-Level Spread
Within a herd, fly transmission during summer months contributes to spread, and blood exposure during calving is possible. Between herds, shared equipment and shared breeding animals are the primary routes.
Clinical Signs
Asymptomatic Carriers (Most Common)
The vast majority of BLV-positive cattle show normal production (though slightly reduced), often live a normal lifespan, and can only be identified through testing.
Persistent Lymphocytosis
These animals carry lymphocyte counts above 10,000/uL (normal runs roughly 4,000-8,000). Counts stay stable over time and may or may not progress to cancer. Most of these animals are still clinically healthy.
Lymphosarcoma (Cancer)
The roughly 5% that develop lymphosarcoma show weight loss, decreased appetite, enlarged lymph nodes, and progressive deterioration. This form is usually fatal within weeks to months.
| Organ Affected | Presentation |
|---|---|
| Heart | Sudden death, heart failure |
| Abomasum (stomach) | Bloat, digestive problems |
| Lymph nodes | Palpable enlargement |
| Spinal cord | Hind leg paralysis |
| Uterus | Reproductive problems |
| Eye | Bulging eye, "cancer eye" |
Economic Impact
Production Losses
| Category | Impact |
|---|---|
| Milk production (dairy) | 3-5% reduction in BLV+ cows |
| Longevity | Earlier culling |
| Immune function | Impaired response to infections |
| Carcass condemnation | Lymphosarcoma at slaughter |
Calculating Herd-Level Impact
In a 100-cow dairy with 40% BLV-positive animals, a 3% milk loss across 40 cows equals 1.2 cow-equivalents of lost production. Factor in the costs of early culling and condemned carcasses, plus potential export restrictions, and the economic argument for control gets hard to ignore.
Export Implications
Many international markets require BLV-free status for semen and embryos, and that growing focus on market access gives producers another good reason to pursue control programs.
Diagnosis
Testing Methods
| Antibody Tests | Sample | Notes |
|---|---|---|
| ELISA | Blood or milk | Common screening test |
| AGID | Blood | Older test, less sensitive |
| Bulk tank ELISA | Tank milk | Herd screening (dairy) |
| Direct Detection | Sample | Notes |
|---|---|---|
| PCR | Blood | Detects viral DNA |
| ELISA (antigen) | Blood | Detects viral protein |
Interpreting Results
A positive antibody test means the animal is infected, will stay positive, and can transmit the virus. A negative result means the animal is either truly negative or recently infected and hasn't seroconverted yet (which takes 2-8 weeks). Retest in 60 days if recent exposure is suspected.
Herd Screening
For dairy operations, bulk tank testing can determine if BLV is present, followed by individual milk ELISA to identify positive cows and blood testing for confirmation. For beef herds, pooled samples offer cost savings, and testing at processing or weaning fits into normal work schedules.
Prevention and Control
Preventing Transmission
| Practice | Protocol |
|---|---|
| Change needles | Between EVERY animal |
| Disinfect instruments | Chlorhexidine or quaternary ammonium between animals |
| Clean ear taggers | Between animals |
| Single-use when possible | Disposable needles, blades |
| Rectal sleeves | Change between animals |
Herd Elimination Programs
A gradual approach works for most operations: test the entire herd, cull clinical cases immediately, segregate positives from negatives if possible, avoid retaining calves from positive cows, retest annually, and cull positives as replacements become available.
An aggressive approach involves culling all positives at once, retesting in 60-90 days, and continuing until the herd tests negative. This is faster but more expensive and not practical for every operation.
For day-to-day management, use separate equipment for positive and negative groups, mark positive animals for easy identification, and don't sell positive animals for breeding purposes.
Preventing Introduction
Require BLV-negative status on all purchased cattle, quarantine and retest new arrivals, and test any leased or borrowed bulls before they enter the herd.
BLV Control Programs
Industry Programs
Voluntary control programs exist in several states, and industry-led initiatives continue to develop. Requirements vary by program. Certification typically involves annual retesting, documented biosecurity measures, and provides marketing value, especially for seedstock operations.
Special Considerations
Beef vs. Dairy
Dairy operations have more testing infrastructure available, including bulk tank testing, and the intensive management style makes control more practical. Beef operations have less routine testing, may see more vector-driven spread, and often overlook BLV control entirely.
Seedstock Producers
BLV status matters for semen and embryo quality, and BLV-free status carries premium value in the seedstock market. Mandatory testing is worth considering for any seedstock operation.
Bulls
Semen should come from BLV-free bulls, and all bulls should be tested before use. AI studs typically test and maintain BLV-free status as standard practice.
Human Health
No Evidence of Human Infection
There are no confirmed human infections from BLV, though some research has explored possible associations. BLV is not considered a food safety issue or a zoonotic concern, and no special handling is required.
Frequently Asked Questions
Q: Should I cull BLV-positive cattle?
Q: Can calves be infected through colostrum?
Q: Is there a vaccine?
Q: How long until new infections test positive?
Bottom Line
BLV is extremely common, affecting an estimated 40-50% of US dairy cattle, yet most infected animals never get sick. Only about 5% develop lymphosarcoma, the fatal cancer form of the disease. The production losses are real even in animals that look perfectly healthy, though. Reduced milk yield, earlier culling, and impaired immune function add up across a herd over time.
The primary transmission route is blood transfer, which makes changing needles between every animal one of the single most effective prevention steps you can take. Testing is straightforward and affordable through ELISA, and control programs are achievable with commitment and consistent biosecurity. BLV-free status also opens doors to export markets that increasingly require disease-free certification.
From a human health standpoint, BLV is not considered a zoonotic disease. There is no evidence of human infection, and no special handling precautions are necessary.
